Centessa Appoints Neuropsychiatrist as Chief Medical Officer
The new CMO brings over 30 years of experience in neuroscience and drug development to Centessa as it advances its orexin receptor 2 agonist portfolio.
The new CMO brings over 30 years of experience in neuroscience and drug development to Centessa as it advances its orexin receptor 2 agonist portfolio.
NSF appoints an expert in population sleep health and disparities as the new editor-in-chief of Sleep Health.
The new chief commercial officer will oversee the US launch of Nyxoah’s Genio neurostimulator for obstructive sleep apnea, pending FDA approval.
Union-Bulletin: Richard Simon Jr. discusses his retirement in his office at the Kathryn Severyns Dement Sleep Disorders Center in Walla Walla.
Leveraging expertise across the health and wellness industry and with a track record in scaling companies, the new CEO will guide the company through its next phase of growth.
Perspectives on staffing ratios at accredited sleep labs and the education requirements for technologists performing attended polysomnography.
The new CMO brings surgical and academic expertise in hypoglossal nerve stimulation.